Effect of troglitazone on radiation sensitivity in cervix cancer cells
Zhengzhe An, Xianguang Liu, Hyejin Song, Chihwan Choi, Won-Dong Kim, Jae-Ran Yu, Woo-Yoon Park
Radiat Oncol J. 2012;30(2):78-87.   Published online 2012 Jun 30     DOI: https://doi.org/10.3857/roj.2012.30.2.78
Citations to this article as recorded by Crossref logo
PPAR-γ Modulators as Current and Potential Cancer Treatments
Tiange Chi, Mina Wang, Xu Wang, Ke Yang, Feiyu Xie, Zehuan Liao, Peng Wei
Frontiers in Oncology.2021;[Epub]     CrossRef
PPARγ Agonists in Combination Cancer Therapies
Piotr Mrowka, Eliza Glodkowska-Mrowka
Current Cancer Drug Targets.2020; 20(3): 197.     CrossRef
Rosiglitazone enhances radiosensitivity by inhibiting repair of DNA damage in cervical cancer cells
Zhengzhe An, Jae-Ran Yu, Woo-Yoon Park
Radiation and Environmental Biophysics.2017; 56(1): 89.     CrossRef
T0070907 inhibits repair of radiation-induced DNA damage by targeting RAD51
Zhengzhe An, Jae-Ran Yu, Woo-Yoon Park
Toxicology in Vitro.2016; 37: 1.     CrossRef
Chemotherapy and Chemoprevention by Thiazolidinediones
Eleonore Fröhlich, Richard Wahl
BioMed Research International.2015; 2015: 1.     CrossRef
A new dawn for the use of thiazolidinediones in cancer therapy
Hardik Joshi, Tanushree Pal, CS Ramaa
Expert Opinion on Investigational Drugs.2014; 23(4): 501.     CrossRef
Troglitazone and tumor inhibition: an evolving concept in the management of systemic malignancies
Shailendra Kapoor
Radiation Oncology Journal.2012; 30(4): 226.     CrossRef